SCHEMBL5674339

SCHEMBL5674339

O=C1CCCc2cc3c(cc21)OCCO3

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.50
MAPK1 P28482 1/20 0.50
KMT2A Q03164 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
MAOA P21397 6/20 0.46
MAOB P27338 6/20 0.46
PRKCI P41743 1/20 0.46
CYP2A6 P11509 1/20 0.42
KDM4E B2RXH2 2/20 0.42
CYP11B2 P19099 3/20 0.41
HSD17B1 P14061 1/20 0.41
CYP2D6 P10635 2/20 0.41
GRM5 P41594 1/20 0.39
BAZ2B Q9UIF8 1/20 0.38
GRIA1 P42261 1/20 0.36
ACHE P22303 1/20 0.35
DRD1 P21728 1/20 0.35
DRD5 P21918 1/20 0.35
GRIA2 P42262 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1243457 0.89 KDM4E (0.54) MEN1MAPK1KMT2ANPSR1MAOA
SCHEMBL4849793 0.88 KDM4E (0.44) MEN1MAPK1KMT2ANPSR1MAOA
SCHEMBL10577512 0.85 MEN1 (0.51) MEN1MAPK1KMT2ANPSR1MAOA
SCHEMBL10574409 0.85 MEN1 (0.51) MEN1MAPK1KMT2ANPSR1MAOA
SCHEMBL1243316 0.85 KDM4E (0.54) MEN1MAPK1KMT2ANPSR1MAOA
SCHEMBL8284440 0.77 MEN1 (0.69) MEN1MAPK1KMT2ANPSR1MAOA
SCHEMBL30390377 0.76 KDM4E (0.58) KMT2AKDM4EHSD17B1CYP2D6ACHE
SCHEMBL6336267 0.76 KDM4E (0.58) KMT2AKDM4EHSD17B1CYP2D6ACHE
SCHEMBL3454654 0.74 MEN1 (0.73) MEN1MAPK1KMT2ANPSR1MAOA
SCHEMBL25271915 0.73 KDM4E (0.42) MEN1MAPK1KMT2ANPSR1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115780-B2 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same SANOFI-AVENTIS (FR) 2006-10-03 US disclosed
US-20050054641-A1 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same SANOFI-AVENTIS (FR) 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054641-A1 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same ALK, CHRM4, CHRM2 MEN1 1820/4885MAPK1 4154/4885KMT2A 3125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.